Question · asked by 1 review
Ceftriaxone vs azithromycin: Serious adverse events
- Population
- children under 18 years of age with enteric fever
- Intervention
- Ceftriaxone
- Comparison
- azithromycin
- Outcome
- Serious adverse events
The review found no eligible studies for this question.
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Ceftriaxone vs azithromycin Serious adverse events · children under 18 years of age with enteric fever The review found no eligible studies for this question. Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins (2022) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins 2022 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Ceftriaxone vs fluoroquinolones · adults and children with enteric fever · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.